Literature DB >> 6265938

Dissection of distinct human immunoregulatory T-cell subsets by a monoclonal antibody recognizing a cell surface antigen with wide tissue distribution.

O H Irigoyen, P V Rizzolo, Y Thomas, M E Hemler, H H Shen, S M Friedman, J L Strominger, L Chess.   

Abstract

A monoclonal antibody, PVR-11, was obtained after hybridization of X63Ag8.653 murine myeloma cells with spleen cells from a mouse immunized with human lymphocytes. It recognizes a 175,000- to 185,000-dalton surface antigen present on approximately 80% of normal human peripheral T lymphocytes, 50% of non-T non-B cells, and less than 10% of B cells as determined by complement-dependent microcytotoxicity. It is also present on various leukemia T cells, on some but not all T lymphoblastoid cell lines, and on a small fraction of some B lymphoblastoid cell lines. Some B-cell chronic lymphocytic leukemia cells also express the PVR-11 antigen. Functional analysis of normal human T lymphocytes demonstrated that the PVR-11-depleted T-cell subset contains the precursors of both cytotoxic and suppressor cells but lacks helper cells. On the other hand, cytotoxic effector T cells express the PVR-11 antigen. These results demonstrate that antigenic determinants with relatively wide tissue distribution can dissect functionally distinct human immunoregulatory T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265938      PMCID: PMC319520          DOI: 10.1073/pnas.78.5.3160

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Cell surface markers for human T and B lymphocytes.

Authors:  G Brown; M F Greaves
Journal:  Eur J Immunol       Date:  1974-04       Impact factor: 5.532

3.  Studies on the human T-lymphocyte population. II. The use of a T-cell specific antibody in the partial isolation and characterization of the human lymphocyte receptor for sheep red blood cells.

Authors:  F L Owen; M W Fanger
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

4.  Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes.

Authors:  F Aiuti; H Wigzell
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

5.  Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.

Authors:  J N Woody; A Ahmed; R C Knudsen; D M Strong; K W Sell
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

6.  Immunologic characterization of chronic lymphocytic leukemia cells.

Authors:  T L Whiteside; A Winkelstein; B S Rabin
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

7.  Enumeration and isolation of human T and B lymphocytes by rosette formation with antibody-coated erythrocytes.

Authors:  A J Strelkauskas; M Teodorescu; S Dray
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

8.  Characterization of a subpopulation of human T lymphocytes reactive with an heteroantiserum to human brain.

Authors:  J Brouet; H Toben
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

9.  Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone.

Authors:  P M Sondel; L Chess; R P MacDermott; S F Schlossman
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens.

Authors:  R L Evans; J M Breard; H Lazarus; S F Schlossman; L Chess
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.